Cargando…

Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

SIMPLE SUMMARY: The proximity extension assay (PEA) method enables the detection of proteins in tissue lysates and plasma with high specificity and sensitivity. Knowledge regarding the immune proteome profile in classical Hodgkin Lymphoma (cHL) tumor microenvironment (TME) is critical in an era of e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gholiha, Alex Reza, Hollander, Peter, Löf, Liza, Larsson, Anders, Hashemi, Jamileh, Ulfstedt, Johan Mattsson, Molin, Daniel, Amini, Rose-Marie, Freyhult, Eva, Kamali-Moghaddam, Masood, Enblad, Gunilla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750205/ https://www.ncbi.nlm.nih.gov/pubmed/35008176 http://dx.doi.org/10.3390/cancers14010009

Ejemplares similares

Checkpoint CD47 expression in classical Hodgkin lymphoma
por: Gholiha, Alex Reza, et al.
Publicado: (2022)

P045: Plasma proteome profiling of cardiotoxicity in patients with Hodgkin lymphoma
por: Ulfstedt, Johan Mattsson, et al.
Publicado: (2022)

Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
por: Mörth, Charlott, et al.
Publicado: (2021)

Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
por: Hollander, Peter, et al.
Publicado: (2018)

Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma
por: Mattsson Ulfstedt, Johan, et al.
Publicado: (2021)

P096: Polymorphisms in SETD7 may predispose the risk of developing late cardiac side effects after radiotherapy including the mediastinum in Hodgkin’ s lymphoma.
por: Linderoth, Johan, et al.
Publicado: (2022)

T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients
por: Övergaard, Ninja, et al.
Publicado: (2022)

Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients
por: Sarén, Tina, et al.
Publicado: (2023)

Plasma Protein Profiling Reveal Osteoprotegerin as a Marker of Prognostic Impact for Colorectal Cancer
por: Birgisson, Helgi, et al.
Publicado: (2018)

Mitochondrial Respiration-Dependent ANT2-UCP2 Interaction
por: Schiffer, Tomas A., et al.
Publicado: (2022)

High risk of cardiovascular side effects after treatment of Hodgkin’s lymphoma – is there a need for intervention in long-term survivors?
por: Andersson, Anne, et al.
Publicado: (2021)

Prognostic impact of abdominal lymph node involvement in diffuse large B‐cell lymphoma
por: Abdulla, Maysaa, et al.
Publicado: (2019)

Marginal zone lymphoma expression of histidine‐rich glycoprotein correlates with improved survival
por: Persson Skare, Tor, et al.
Publicado: (2020)

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy
por: Lagerlöf, Ingemar, et al.
Publicado: (2022)

Hodgkin lymphoma – a survey of children and adolescents treated in Sweden 1985–2009
por: Englund, Annika, et al.
Publicado: (2015)

P091: Early analysis of the PRO-Hodgkin study: Clinical investigation of pencil beam scanning proton treatment in Hodgkin lymphoma patients
por: Goldkuhl, Christina, et al.
Publicado: (2022)

Monitoring of Protein Biomarkers of Inflammation in Human Traumatic Brain Injury Using Microdialysis and Proximity Extension Assay Technology in Neurointensive Care
por: Dyhrfort, Philip, et al.
Publicado: (2019)

Surface protein profiling of prostate-derived extracellular vesicles by mass spectrometry and proximity assays
por: Manouchehri Doulabi, Ehsan, et al.
Publicado: (2022)

A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients
por: Lind, Anne-Li, et al.
Publicado: (2016)

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma
por: Nikkarinen, Anna, et al.
Publicado: (2023)

Genetics of classical Hodgkin Lymphoma
por: Schiavoni, Gianluca, et al.
Publicado: (2018)

Detecting individual extracellular vesicles using a multicolor in situ proximity ligation assay with flow cytometric readout
por: Löf, Liza, et al.
Publicado: (2016)

Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia
por: Löf, Liza, et al.
Publicado: (2017)

The molecular mechanisms of classic Hodgkin's lymphoma.
por: Felberbaum, Rachael S.
Publicado: (2005)

Immunological Deregulation in Classic Hodgkin Lymphoma
por: Romano, Alessandra, et al.
Publicado: (2014)

Controversies in the Treatment of Classical Hodgkin Lymphoma
por: Eichenauer, Dennis A., et al.
Publicado: (2018)

The Grey Zones of Classic Hodgkin Lymphoma
por: Bosch-Schips, Jan, et al.
Publicado: (2022)

Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?
por: Mörth, Charlott, et al.
Publicado: (2018)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
por: Dogan, Ahmet
Publicado: (2022)

Bob-1 is expressed in classic Hodgkin lymphoma
por: Abd El All, Howayda S
Publicado: (2007)

Resources-Stratified Guidelines for Classical Hodgkin Lymphoma
por: Relecom, Allan, et al.
Publicado: (2020)

MicroRNA signature in classical Hodgkin lymphoma
por: Paczkowska, Julia, et al.
Publicado: (2021)

Composite follicular lymphoma and classic Hodgkin lymphoma
por: Kim, Han-Na, et al.
Publicado: (2022)

Bone marrow involvement by classic Hodgkin lymphoma
por: Barouqa, Mohammad, et al.
Publicado: (2022)

Aberrant synaptophysin expression in classic Hodgkin lymphoma
por: Im, Soyoung, et al.
Publicado: (2022)

Current directions in the treatment of classical Hodgkin lymphoma
por: Keller, Frank G., et al.
Publicado: (2023)

CAR-T Cell Therapy for Classical Hodgkin Lymphoma
por: Katsin, Mikalai, et al.
Publicado: (2023)

Sex- and Female Age-Dependent Differences in Gene Expression in Diffuse Large B-Cell Lymphoma—Possible Estrogen Effects
por: Huang, Dan, et al.
Publicado: (2023)

Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling
por: Honoré, Bent, et al.
Publicado: (2022)

The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future
por: Richardson, S. E., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vh3p719smeqooq2mg82rmlc57o